echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The price difference of similar drugs exceeds 2 times, and it needs to be reduced by 30% or 2 times the lowest price!

    The price difference of similar drugs exceeds 2 times, and it needs to be reduced by 30% or 2 times the lowest price!

    • Last Update: 2021-07-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
      Medical Network, February 24 News On February 22, Jiangxi issued a public solicitation of the "Implementation Plan for the Reform and Improvement of Pharmaceutical and Medical Consumables Sunshine Centralized Online Purchasing Work in Jiangxi Province (Second Draft for Solicitation of Comments)"
    .
    It is worth noting that Jiangxi stipulates that when the price of similar products is 2 times or more than the lowest price, it must be reduced by 30% or reduced to 2 times the lowest price

    .
    This requirement was not mentioned in the first draft for comments

    .
    At the same time, drugs with red-line price adjustments are not accepted, and all specifications and packaging of the drugs are adjusted from the procurement catalog to the alternative catalog, and they face suspension of procurement

    .
    The deadline for soliciting opinions is March 1

    .

      The price difference of similar drugs has more than doubled and the price needs to be reduced for
    nearly two years.
    At the provincial drug procurement level, in addition to the implementation of mass procurement, the drug procurement model has also ushered in a new change

    .
    The Jiangxi plan shows that the organizational role of the medical insurance department and the enthusiasm of medical institutions will be brought into play.
    Medical institutions and manufacturing companies will conduct independent online price bargaining in accordance with regulations, and encourage medical institutions to form purchasing alliances or cross-regional specialist purchasing alliances to group purchases

    .
    For the price requirements that the industry is most concerned about, Jiangxi will refer to the purchase prices of the province and other provinces, adopt price linkage, set a "red, yellow, and green" price guideline, implement "red line interception, yellow line reminder, green line encouragement" to guide prices back to reasonable Interval

    .
    "Red line" interception: The average of the highest and lowest prices of provincial centralized purchase prices in 15 provinces is used as the red line price.
    The

    15 provinces include Beijing, Tianjin, Shanghai, Jiangsu, Zhejiang, Guangdong, Chongqing, Anhui, Fujian, Shandong, Henan , Hebei, Liaoning, Hubei and Hunan
    .
    The agreed transaction price of medical institutions shall not be higher than the red line price, otherwise the system will be locked and the bargaining result cannot be verified

    .
    The lowest value of the three prices of the average of the lowest price, the original winning bid price in Jiangxi Province, and the online weighted purchase price in Jiangxi Province in the past year is the yellow line price

    .
    When the negotiated transaction price of the medical institution is higher than the yellow line price, the system will automatically remind you

    .
    In the online procurement, the price of the yellow line is adjusted dynamically in real time

    .
    "Green line" encouragement: the lowest value of the three lowest prices of the 15 provincial centralized procurement prices, the original winning bid price in Jiangxi Province, and the lowest online procurement price in Jiangxi Province in the past year is the green line price

    .
    Encourage medical institutions to negotiate purchases below the green line price

    .
    In the online procurement work, the green line price is adjusted dynamically in real time

    .
    Compared with the last round of procurement plans, the Jiangxi new version of the plan has undergone major changes in rules and requirements, and follows the example of Shanghai, Jiangsu, Sichuan and other places to set up a "three-color area" for bargaining

    .
    More importantly, Jiangxi has made strict regulations on the price of similar
    drugs : that is, when the price of similar products is 2 times or more than the lowest price, it must be reduced by 30% or reduced to 2 times the lowest price
    .
    For medicines with a large price gap, it is believed that whether it is a 30% reduction or a reduction to 2 times the minimum price will have a significant impact on their prices

    .
    Especially for original research drugs and high-priced drugs, it will bring greater pressure to reduce prices

    .

      These drugs are facing suspension of procurement.

    Another noteworthy point is that, unlike the current localized procurement of drugs in several categories, Jiangxi divides the online catalog into only two categories: procurement catalogs and alternative catalogs

    .
    The medicines and medical consumables in the procurement catalog should be products that have online procurement requirements or implement the centralized procurement policy, and the online bargaining procurement function is activated and available, and the medical institution and the manufacturing
    company will immediately carry out online bargaining procurement in accordance with regulations
    .
    The medicines and medical consumables in the alternative catalogues are generally newly listed products that have been applied for procurement on the provincial network or products that have been suspended for reasons such as no procurement needs.
    The online bargaining procurement function is disabled, and online bargaining procurement cannot be carried out immediately.

    .
    For which varieties will enter the candidate list? Specifically, pharmaceuticals and medical consumables that have been linked to the Internet will be included in the candidate list if there is no purchase record within one year before the implementation of this program

    .
    In addition, for newly-listed medicines and medical consumables to be purchased online in Jiangxi Province, manufacturers will register dynamically, and related products will also be included in the candidate list after publicity

    .
    At the same time, the catalog is dynamically adjusted

    .
    Gynecology and children specialty generic drugs, emergency (rescue) drugs, basic infusions, drugs that are easy to be short of, generic drugs of nationally negotiated drugs, drugs that have passed consistency evaluation, and drugs that are exclusively produced and supplied and do not have the same route of administration in the procurement catalog Automatically enter the procurement catalog; newly listed drugs that are applied for online procurement in Jiangxi Province and have 5 or more provincial centralized procurement prices are automatically entered into the procurement catalog; there are medical institutions in Jiangxi Province (1 or more tertiary medical institutions or 3 and above secondary medical institutions) submit purchase applications, enter the purchase catalog

    .
    In addition, Jiangxi also stipulates that the red-line price of drugs that fail the consistency evaluation shall not be higher than the red-line price of drugs that pass the consistency evaluation, and the red-line price of drugs that pass the consistency evaluation shall not be higher than the red-line price of the original drug or the reference preparation, otherwise it will be reduced.
    To the red line price of the original drug, the reference preparation or the drug that passed the consistency evaluation

    .
    The price of newly registered products shall not be higher than the highest online redline price of other companies in the same category

    .
    Drugs whose prices are adjusted by the red line above are not accepted, and all specifications and packaging of the drugs are adjusted from the procurement catalog to the alternative catalog

    .
    In this regard, companies need to pay attention to the rules and adjust prices to prevent products from entering the alternative catalog facing suspension of procurement

    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.
    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.